The complex world of software-defined medical devices, from smart orthopedic implants to autonomous surgical robots, just saw a significant investment. Inner Logic, a company building the computational development infrastructure for these next-generation procedural devices, has secured $11.5M in seed funding.
General Catalyst led the round for Inner Logic, which provides the foundational tools to help device programs move from concept to evidence-backed iteration, overnight and at scale. The company's technology addresses the challenge of ensuring intelligent and autonomous devices perform to higher standards, beyond what better models and larger datasets alone can achieve.
.png&w=3840&q=75)
